{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:03:42Z","timestamp":1795194222451,"version":"4.10.3"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:p>\n                    In recent years, an increasing number of observational studies have reported the influence of immunity and antibodies on nonalcoholic fatty liver disease (NAFLD). However, no Mendelian randomization (MR) studies have yet been conducted to investigate the causal relationship in NAFLD. Based on a 2-sample MR framework, this study conducted MR analyses between 46 antibody immune response phenotypes and NAFLD using data from 2 different sources. Subsequently, the primary results from the inverse-variance weighted method were subjected to meta-analysis, and multiple testing correction was applied to the meta-analysis thresholds to ensure result accuracy. Finally, reverse MR analyses were performed to examine potential reverse causality between the antibody immune response phenotypes and NAFLD. MR analyses were conducted between 46 antibody immune response phenotypes and NAFLD using data from both the FinnGen R12 and the OpenGWAS databases. The inverse-variance weighted results from the 2 datasets were then combined through meta-analysis, and multiple testing correction was applied to the significance thresholds. The meta-analysis revealed an odds ratio of 1.06 (95% confidence interval: 1.02\u20131.11,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.004). Moreover, the positive antibody immune response phenotype \u2013\n                    <jats:italic toggle=\"yes\">Helicobacter pylori<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                    ) urease antibody levels \u2013 did not show evidence of reverse causality with NAFLD in either of the 2 datasets. The antibody immune response phenotype\n                    <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                    urease antibody levels is a risk factor for NAFLD, with the risk increase explicitly quantified as approximately 6% based on MR analysis.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047386","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:02:38Z","timestamp":1769965358000},"page":"e47386","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Causal validation of immune antibody responses and nonalcoholic fatty liver disease: Evidence from Mendelian randomization and meta-analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Zhengyi","family":"Zhao","sequence":"first","affiliation":[{"name":"Hangzhou Stomatology Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Guo","sequence":"additional","affiliation":[{"name":"Zhejiang Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Hong","sequence":"additional","affiliation":[{"name":"Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2944-7224","authenticated-orcid":false,"given":"Linzhe","family":"Miao","sequence":"additional","affiliation":[{"name":"Zhejiang Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/hep.28584","article-title":"Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Lonardo","year":"2016","journal-title":"Hepatology"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","article-title":"Epidemiology of non-alcoholic fatty liver disease in China.","volume":"50","author":"Fan","year":"2009","journal-title":"J Hepatol"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights.","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2010.01.008","article-title":"Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations.","volume":"52","author":"Lee","year":"2010","journal-title":"J Hepatol"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jpeds.2021.08.041","article-title":"Prevalence and clinical significance of autoantibodies in children with overweight and obesity with nonalcoholic fatty liver disease.","volume":"239","author":"Khayat","year":"2021","journal-title":"J Pediatr"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","article-title":"Pathophysiology of COVID-19-associated acute kidney injury.","volume":"17","author":"Legrand","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"101530","DOI":"10.1016\/j.jcmgh.2025.101530","article-title":"Interorgan and transcellular communication in metabolic disease: insights from recent CMGH studies.","volume":"19","author":"Dong","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis.","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12916-023-02761-6","article-title":"Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study.","volume":"21","author":"Long","year":"2023","journal-title":"BMC Med"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/JS9.0000000000001840","article-title":"The association between immune cells and breast cancer: insights from Mendelian randomization and meta-analysis.","volume":"111","author":"Xu","year":"2025","journal-title":"Int J Surg"},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"25644","DOI":"10.1038\/s41598-024-77105-2","article-title":"Causal relationships between three plasma proteins and non-alcoholic fatty liver disease, mediated by Epstein-Barr virus EA-D antibody levels: a Mendelian randomization study.","volume":"14","author":"Ming","year":"2024","journal-title":"Sci Rep"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"ofaa450","DOI":"10.1093\/ofid\/ofaa450","article-title":"Genetic determinants of antibody-mediated immune responses to infectious diseases agents: a genome-wide and HLA association study.","volume":"7","author":"Butler-Laporte","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"100437","DOI":"10.1016\/j.xcrm.2021.100437","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease.","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2337\/db22-0110","article-title":"A guide for selection of genetic instruments in Mendelian randomization studies of type 2 diabetes and HbA1c: toward an integrated approach.","volume":"72","author":"Garfield","year":"2023","journal-title":"Diabetes"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"e12576","DOI":"10.1111\/hel.12576","article-title":"Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systematic review and meta-analysis of observational studies.","volume":"24","author":"Zhou","year":"2019","journal-title":"Helicobacter"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1002\/cam4.3051","article-title":"Non-genetic biomarkers and colorectal cancer risk: umbrella review and evidence triangulation.","volume":"9","author":"Zhang","year":"2020","journal-title":"Cancer Med"},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/ccr3.687","article-title":"Helicobacter pylori overcomes natural immunity in repeated infections.","volume":"4","author":"Stenstr\u00f6m","year":"2016","journal-title":"Clin Case Rep"},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2049-1891-5-14","article-title":"Evaluating the immune responses of mice to subcutaneous immunization with Helicobacter pylori urease B subunit.","volume":"5","author":"Sun","year":"2014","journal-title":"J Anim Sci Biotechnol"},{"key":"R24-20260519","doi-asserted-by":"crossref","first-page":"e0286731","DOI":"10.1371\/journal.pone.0286731","article-title":"Cognitive function in UK adults seropositive for Helicobacter pylori.","volume":"18","author":"Erickson","year":"2023","journal-title":"PLoS One"},{"key":"R25-20260519","doi-asserted-by":"crossref","first-page":"eadi8646","DOI":"10.1126\/sciadv.adi8646","article-title":"Use of bidirectional Mendelian randomization to unveil the association of Helicobacter pylori infection and autoimmune thyroid diseases.","volume":"10","author":"Wang","year":"2024","journal-title":"Sci Adv"},{"key":"R26-20260519","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1038\/s41598-025-89981-3","article-title":"Assessment of the bidirectional causal association between Helicobacter pylori infection and allergic diseases by Mendelian randomization analysis.","volume":"15","author":"Fan","year":"2025","journal-title":"Sci Rep"},{"key":"R27-20260519","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review.","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"R28-20260519","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/v15051072","article-title":"The intersection of COVID-19 and metabolic-associated fatty liver disease: an overview of the current evidence.","volume":"15","author":"Buchynskyi","year":"2023","journal-title":"Viruses"},{"key":"R29-20260519","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R30-20260519","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/MCG.0000000000001218","article-title":"Helicobacter pylori infection: one more contributor to nonalcoholic fatty liver disease pathophysiology.","volume":"53","author":"Polyzos","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"R31-20260519","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.metabol.2019.04.012","article-title":"Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: an updated meta-analysis.","volume":"96","author":"Mantovani","year":"2019","journal-title":"Metab Clin Exp"},{"key":"R32-20260519","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.3748\/wjg.v19.i41.7024","article-title":"Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.","volume":"19","author":"Li","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R33-20260519","doi-asserted-by":"crossref","first-page":"1282956","DOI":"10.3389\/fcimb.2023.1282956","article-title":"An update: is there a relationship between H. pylori infection and nonalcoholic fatty liver disease? Why is this subject of interest?","volume":"13","author":"Chen","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R34-20260519","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/S0004-28032014000300017","article-title":"Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study.","volume":"51","author":"Polyzos","year":"2014","journal-title":"Arq Gastroenterol"},{"key":"R35-20260519","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity.","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R36-20260519","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/1751-2980.12367","article-title":"Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis.","volume":"17","author":"Upala","year":"2016","journal-title":"J Dig Dis"},{"key":"R37-20260519","doi-asserted-by":"crossref","first-page":"1410543","DOI":"10.3389\/fnut.2024.1410543","article-title":"Bidirectional relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: insights from a comprehensive meta-analysis.","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Nutr"},{"key":"R38-20260519","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1017\/erm.2023.17","article-title":"Helicobacter pylori virulence factors: subversion of host immune system and development of various clinical outcomes.","volume":"25","author":"Mohammadzadeh","year":"2023","journal-title":"Expert Rev Mol Med"},{"key":"R39-20260519","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2183\/pjab.93.013","article-title":"Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer.","volume":"93","author":"Hatakeyama","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"R40-20260519","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"R41-20260519","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.3748\/wjg.v24.i29.3204","article-title":"Helicobacter pylori and extragastric diseases: a review.","volume":"24","author":"Gravina","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R42-20260519","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.3748\/wjg.v25.i37.5578","article-title":"Pathogenesis and clinical management of Helicobacter pylori gastric infection.","volume":"25","author":"de Brito","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R43-20260519","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1499-3872(16)60098-X","article-title":"Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles.","volume":"16","author":"Zhang","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R44-20260519","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis.","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"R45-20260519","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report.","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"R46-20260519","doi-asserted-by":"crossref","first-page":"e12537","DOI":"10.1111\/hel.12537","article-title":"Helicobacter pylori and non-alcoholic fatty liver disease: a new enigma?","volume":"23","author":"Abdel-Razik","year":"2018","journal-title":"Helicobacter"},{"key":"R47-20260519","doi-asserted-by":"crossref","first-page":"997018","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications.","volume":"12","author":"Fang","year":"2022","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:04:36Z","timestamp":1779195876000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047386","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-06-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}